JUSTIN MILLER: Open Payments
NPI 1538691852 · CRESTVIEW HILLS, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,242 in 128 payments from 16 companies in 2025. Trend: 2023 $2,130 · 2024 $2,364 · 2025 $2,242
Food & beverage: $2,242
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 17 | $343 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 18 | $257 |
| Otsuka America Pharmaceutical, Inc. | 20 | $233 |
| Alkermes, Inc. | 9 | $223 |
| Neurocrine BioSciences, Inc. | 14 | $217 |
| Lundbeck LLC | 8 | $182 |
| Vanda Pharmaceuticals Inc. | 7 | $167 |
| Axsome Therapeutics, Inc. | 10 | $162 |
| Teva Pharmaceuticals USA, Inc. | 6 | $125 |
| Takeda Pharmaceuticals U.S.A., Inc. | 5 | $88 |
Products named: VRAYLAR, CAPLYTA, ARISTADA, INGREZZA, REXULTI, ABILIFY MAINTENA, HETLIOZ, Auvelity.
Industry payments across KY — which companies pay providers there.
